Inhibition of proinflammatory cytokine production by pravastatin

Lancet

Volumn 353, Issue 9157, 1999, Pages 983-984

  Rosenson, Robert S ^a   Tangney, Christine C ^a   Casey, Larry C ^a  

^a NW University Medical School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; PRAVASTATIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0033586472     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)05917-0     Document Type: Article

References (4)

1. Rosenson R.S., Tangney C.C. Anti-atherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA. 279:1998;1643-1650.
2. Strandberg T.E., Vanhanen H., Tikkanen M.J. Effet of statins on C-reactive protein in patients with coronary artery disease. Lancet. 353:1999;118-119.
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 340:1999;115-126.
4. Parker T.S., Levine D.M., Chang J.C.C., Laxer J., Coffin C.C., Rubin A.L. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccarides in human whole blood. Infect Immun. 63:1995;253-258.